Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations
Tomohiro Kato (Himeji, Japan), Tomohiro Kato, Yasuharu Nakahara, Katsuya Hirano, Ryota Kominami, Yasutaka Onishika, Yasushi Fukuda, Ryogo Kagami, Runko Katsuda, Kenji Hanaoka, Yoko Yokoi, Kouhei Miyake, Yasuyuki Mizumori, Hiroaki Tsukamoto, Shin Sasaki, Tetsuji Kawamura, Yoshiro Mochizuki
Source: International Congress 2016 – Prognostic variables in lung cancer I
Session: Prognostic variables in lung cancer I
Session type: Thematic Poster
Number: 2861
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tomohiro Kato (Himeji, Japan), Tomohiro Kato, Yasuharu Nakahara, Katsuya Hirano, Ryota Kominami, Yasutaka Onishika, Yasushi Fukuda, Ryogo Kagami, Runko Katsuda, Kenji Hanaoka, Yoko Yokoi, Kouhei Miyake, Yasuyuki Mizumori, Hiroaki Tsukamoto, Shin Sasaki, Tetsuji Kawamura, Yoshiro Mochizuki. Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations. Eur Respir J 2016; 48: Suppl. 60, 2861
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Prognostic value of smoking status in operated non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 40s Year: 2004
Prognostic parameters in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006
Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013
MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015
Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013
Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015
Prognostic factors affecting survival in advanced non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004
Prognostic value of comorbidity in operated non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006
Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014
The effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016
Clinical features and prognosis of multiple primary malignancies in patients with lung cancer Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
Prognostic factors for stage IV lung adenocarcinoma patients receiving retreatment with EGFR-TKI Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012
Locally advanced and metastatic lung cancer management delay: Tunisian department experience Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016
Prognostic relevance of histological subtypes in lung cancer – Survival in frequent and rare entities Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
Prevalence of mutations in Romanian patients with non-squamous lung carcinoma evaluated through next generation sequencing Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016
Prognostic relevance of the new lung cancer classification in operable stages Source: International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science Year: 2014
Development and validation of a prognostic index for survival in patients with non-small-cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016
Prognostic parameters in non-small cell lung cancer (211 cases) Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002